Image Source: The Economic Times
Sigachi Industries Ltd has announced a Board meeting to consider raising funds, potentially via FCCBs. The pharma company aims to use capital for expansion, R&D, and global partnerships. Shares remain volatile, but analysts believe fundraising could strengthen liquidity and competitiveness, marking a key step in its growth journey.
Show more
Pharmaceutical player Sigachi Industries Ltd is back in the spotlight as its Board of Directors prepares to consider raising funds in an upcoming meeting. The Hyderabad-based company, listed on both NSE and BSE, is exploring options to strengthen its balance sheet and support expansion initiatives.
Key Highlights
-
Fundraising Proposal: The company has indicated that the Board will deliberate on raising capital, with market speculation pointing towards instruments such as Foreign Currency Convertible Bonds (FCCBs).
-
Market Performance: Shares of Sigachi have seen volatility in recent months, trading around ₹34–36 levels, with a sharp fall from its 52-week high of nearly ₹60.
-
Growth Ambitions: Sigachi, known for its pharmaceutical excipients and specialty chemicals, is expected to channel new funds into capacity expansion, R&D, and global partnerships.
-
Investor Buzz: Analysts note that fundraising could help the company reduce debt and improve liquidity, making it more competitive in the pharma supply chain.
This development underscores how small-cap pharma firms are leveraging capital markets to scale operations and tap global opportunities, especially amid rising demand for healthcare solutions.
Sources: Trendlyne , Moneycontrol, Goodreturns
Stay Ahead – Explore Now!
Tax Notice Alert: Kokuyo Camlin Faces ₹95 Lakh GST Demand
Advertisement
Advertisement